Jane Chwick
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 5, 2026
Voya Financial Faces Proxy Fight and Fund Reorganizations. Voya Financial is navigating a corporate governance challenge as TOMS Capital initiates a proxy fight, which some analysts suggest may indicate the stock is undervalued. Simultaneously, the company is reorganizing its Asia Pacific and Emerging Markets funds, leading to temporary trading suspensions. These developments occur alongside routine updates, including the scheduling of third-quarter 2026 results and new research on consumer financial confidence.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
MTB Q3 Earnings Beat on NII, Stock Slides on Cost Concerns. M&T Bank reported third‑quarter earnings that topped analysts’ expectations, driven by higher net interest income. The results also highlighted rising expenses, which pushed the share price lower after the release. Analysts noted that the upside case remains intact despite the cost pressure. The stock is currently near its recent support level.
Transaction History
| MKTX | ▼ Sell | Gift | 606 | $0 | 8/7/2026 | View on chart |
| MKTX | ▲ Buy | Grant | 1,390 | $0 | 6/10/2026 | View on chart |
| VOYA | ▲ Buy | Option Exercise | 2,547 | $0 | 5/21/2026 | View on chart |
| MTB | ▲ Buy | Grant | 664 | $0 | 4/30/2026 | View on chart |
| MKTX | ▲ Buy | Grant | 784 | $0 | 6/4/2025 | View on chart |
| VOYA | ▲ Buy | Option Exercise | 2,055 | $137K | 5/22/2025 | View on chart |
| MTB | ▲ Buy | Grant | 855 | $0 | 4/30/2025 | View on chart |
| MKTX | ▼ Sell | Gift | 381 | $0 | 12/2/2024 | View on chart |
| MKTX | ▲ Buy | Grant | 781 | $0 | 6/5/2024 | View on chart |
| VOYA | ▲ Buy | Option Exercise | 2,165 | $0 | 5/23/2024 | View on chart |
| MTB | ▲ Buy | Grant | 935 | $0 | 4/30/2024 | View on chart |
| MKTX | ▲ Buy | Grant | 581 | $0 | 6/7/2023 | View on chart |
| VOYA | ▲ Buy | Option Exercise | 2,074 | $144K | 5/26/2023 | View on chart |
| MTB | ▲ Buy | Grant | 954 | $0 | 4/28/2023 | View on chart |
| MKTX | ▲ Buy | Grant | 497 | $0 | 6/8/2022 | View on chart |
| MTB | ▲ Buy | Grant | 721 | $0 | 4/29/2022 | View on chart |
| MTB | ▲ Buy | Grant | 2,865 | — | 4/1/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
MarketAxess Reports Q2 Earnings and New Data Integration
MarketAxess released its Q2 earnings, showing the company’s performance in the fixed‑income market. The firm also announced that Arcesium will use more MarketAxess data and analytics to improve fixed‑income workflows, which could broaden its reach. Analysts note that while the stock is trading near the top of its 52‑week range, it is compared to BGC as a potential value play, and some analysts warn it could drop sharply in October.
MarketAxess Reports Q2 Earnings and New Data Integration. MarketAxess released its Q2 earnings, showing the company’s performance in the fixed‑income market. The firm also announced that Arcesium will use more MarketAxess data and analytics to improve fixed‑income workflows, which could broaden its reach. Analysts note that while the stock is trading near the top of its 52‑week range, it is compared to BGC as a potential value play, and some analysts warn it could drop sharply in October.